Citations

Mayo Clinic

Showing 10 of 108551 citations.

Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer: A Narrative Review
Ycaza, Ana E. Espinosa De, Brito, Juan P. , Ospina, Naykky Singh , Ospina, Naykky Singh , Singh Ospina, Naykky , Brito, Juan P , McCoy, Rozalina G. , Shao, Hui

Thyroid® | February 12, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1089/thy.2023.0530 | PMID 38343381 Get It

Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study
Karadağ, Ömer , Bölek, Ertuğrul Çağrı , Ayan, Gizem , Mohammad, Aladdin J , Grayson, Peter C. , Pagnoux, Christian , Martín‐Nares, Eduardo , Monti, Sara , Abe, Yoshiyuki , Alberici, Federico , Alıbaz-Öner, Fatma , Cuthbertson, David , Koening, Curry L. , Langford, Carol A. , McAlear, Carol A. , Hočevar, Alojzija , Hinojosa‐Azaola, Andrea , Furuta, Shunsuke , Emmi, Giacomo , Özen, Seza , Collaborators, for the GLOBAL‐PAN, Springer, Jason , Simonini, Gabriele , Di̇reskeneli̇, Haner , Khalidi, Nader A , McAlear, Carol A , Warrington, Kenneth J , Hocevar, Alojzija , Hinojosa-Azaola, Andrea , Ozen, Seza , Jayne, David , Merkel, Peter A , Springer, Jason M , Monti, Sara , Pagnoux, Christian , Mohammad, Aladdin J , Dagna, Lorenzo , Khalidi, Nader , Monach, Paul A. , Moroni, Luca , Padoan, Roberto , Seo, Philip , Warrington, Kenneth J. , Jayne, David , Merkel, Peter A. , Collaborators, for the GLOBAL‐PAN

Arthritis & Rheumatology | February 12, 2024 | Volume: 76 | Issue: 7 | Pages: 1120-1129

10.1002/art.42817 | PMID 38343337 Get It

Objective We describe the demographics, clinical features, disease course, and survival of polyarteritis nodosa (PAN) through an international collaboration (GLOBAL‐PAN). Methods Patients with PAN were recruited between 1990 and 2020 from observational cohorts of nine countries across Europe, Japan, and North America. Eligibility was retrospectively defined using the European Medicines Agency classification algorithm. Patients with PAN related to hepatitis B virus (n = 12) and two monogenic diseases mimicking PAN, deficiency of adenosine deaminase 2 enzyme (n = 16) or familial Mediterranean fever (n = 11), were excluded. Data regarding organ involvement, relapse, disease‐related damage, and survival were analyzed. Results Three hundred fifty‐eight patients (female:male ratio 174:184), including those with systemic PAN (sPAN, n = 282) and cutaneous PAN (n = 76), were included. Twenty‐five were pediatric onset. Mean ± SD age at diagnosis was 44.3 ± 18.1 years. Constitutional symptoms (71.5%), cutaneous involvement (70.5%), musculoskeletal findings (69.1%), and neurologic features (48.0%) were common manifestations. Among patients with sPAN, gastrointestinal involvement and proteinuria over 400 mg/day were reported in 52.2% and 11.2%, respectively. During a median (interquartile range) 59.6 (99.5) months of follow‐up, relapse occurred in 48.5% of patients. One, 5‐ and 10‐year survival rates for sPAN were 97.1%, 94.0%, and 89.0%, respectively. Predictors of death for sPAN included age ≥65 years at diagnosis, serum creatinine at diagnosis >140 μmol/L, gastrointestinal manifestations, and central nervous system (CNS) involvement. Conclusion The spectrum of PAN remains a complex, multifaceted disease. Relapse is common. Age ≥65 years and serum creatinine >140 μmol/L at diagnosis, as well as gastrointestinal and CNS involvement, are independent predictors of death in sPAN. image
Radiotherapy‐Induced Astrocyte Senescence Promotes an Immunosuppressive Microenvironment in Glioblastoma to Facilitate Tumor Regrowth
Ji, Jianxiong , Ding, Kaikai, Huang, Bin , Hao, Yu , Chen, Yike , Xu, Xiaohui, Lin, Haopu, Zhou, Jiayin , Wang, Tingtin, Jin, Mengmeng , Liu, Aixia , Yan, Danfang, Liu, Fuyi, Wang, Chun , Chen, Jingsen, Wang, Lin , Zhang, Jianmin , Yan, Senxiang , Wang, Jian , Li, Xingang , Gao, Chen , Cheng, Bo , Zhang, Xin , Luo, Tao , Yan, Feng

Advanced Science | February 11, 2024 | Volume: 11 | Issue: 15 | Pages: No page available

10.1002/advs.202304609 | PMID 38342629 Get It

Abstract Accumulating evidence suggests that changes in the tumor microenvironment caused by radiotherapy are closely related to the recurrence of glioma. However, the mechanisms by which such radiation‐induced changes are involved in tumor regrowth have not yet been fully investigated. In the present study, how cranial irradiation‐induced senescence in non‐neoplastic brain cells contributes to glioma progression is explored. It is observed that senescent brain cells facilitated tumor regrowth by enhancing the peripheral recruitment of myeloid inflammatory cells in glioblastoma. Further, it is identified that astrocytes are one of the most susceptible senescent populations and that they promoted chemokine secretion in glioma cells via the senescence‐associated secretory phenotype. By using senolytic agents after radiotherapy to eliminate these senescent cells substantially prolonged survival time in preclinical models. The findings suggest the tumor‐promoting role of senescent astrocytes in the irradiated glioma microenvironment and emphasize the translational relevance of senolytic agents for enhancing the efficacy of radiotherapy in gliomas.
Barriers and Facilitators Impacting Disease and Symptom Management Among College Students With Type 1 Diabetes: A Qualitative Study
McFadden, Ny’Nika T. , Wilkerson, Amanda H. , Jaiswal, Jessica , Chaney, Beth H. , Lovett, Kylie , Carmack, Heather J. , Stellefson, Michael

American Journal of Health Promotion | February 11, 2024 | Volume: 38 | Issue: 5 | Pages: 704-715

10.1177/08901171241233407 | PMID 38342487 Get It

Purpose This study aimed to explore barriers and facilitators impacting disease and symptom management among college students living with Type 1 Diabetes (T1D). Design A qualitative, phenomenological approach using semi-structured, one-on-one interviews. Setting Interviews conducted on Zoom (n = 28) and in-person (n = 3). Participants Purposive sample of 31 college students living with T1D for at least 2 years who attended large, 4-year public universities in the Southeastern United States. Method This study was theoretically informed using the Middle-Range Theory of Self-Care of Chronic Illness Integration of Symptoms to develop interview questions. Interviews were transcribed verbatim and uploaded in NVivo. Data were analyzed thematically using a codebook developed by the research team using the theory as a framework. Trustworthiness was established using an audit trail, memos, and negative case analysis. Results Four themes described barriers: diabetes burnout, challenges adjusting to a college lifestyle, difficulty receiving medical supplies, and insurance limitations. Five themes explained facilitators: years of experience managing T1D, tangible support with medical supplies, informational support for disease management, and emotional/technological support for disease and symptom management. Conclusion Barriers and facilitators in this study should be addressed in future T1D interventions for college students. Findings can also guide healthcare professionals, health promotion practitioners, family, friends, and significant others on how to better support college students as they manage T1D.
A new initiative for the Journal of the National Cancer Institute: supporting early career investigators
Sherman, Mark E. , Boehm, Amanda L. , Franco, Eduardo L.

JNCI: Journal of the National Cancer Institute | February 11, 2024 | Volume: 116 | Issue: 3 | Pages: 341-342

10.1093/jnci/djae015 | PMID 38341802 Get It

Utility of routine follow‐up defibrillation safety margin testing in young patients with epicardial implantable cardioverter‐defibrillators
Leng, Tomas , Stephens, Elizabeth H. , Cannon, Bryan C. , Ackerman, Michael J. , Wackel, Philip L. , Griffeth, Elaine, Cannon, Bryan C , Wackel, Philip , Griffeth, Elaine M. , Dearani, Joseph A.

Pacing and Clinical Electrophysiology | February 11, 2024 | Volume: 47 | Issue: 3 | Pages: 392-397

10.1111/pace.14948 | PMID 38341633 Get It

AbstractBackgroundRoutine defibrillation threshold testing (DFT) of transvenous implantable defibrillators (ICDs) has largely been in decline. In patients with non‐transvenous ICDs that utilize subcutaneous and pleural ICD leads, serial DFT testing can detect a significant number of failures. Data about the utility of follow‐up defibrillation safety margin testing (DSM) testing in pediatric patients and young adults with an epicardial ICD are lacking.MethodsPatients aged < 25 years old who underwent epicardial ICD placement at Mayo Clinic from 2014 to 2023 with at least one follow‐up DSM test were included. The patients were divided into a “routine” (R) and “clinically indicated” (CI) group based on the index of clinical concern. Inadequate DSM was defined as unsuccessful defibrillation at an output of less than 10 J below the maximum output of the device. The purpose of this study was to assess the utility of follow‐up DSM testing.ResultsAn epicardial ICD system was placed in 122 patients. A total of 26 patients met inclusion criteria and underwent a total of 47 DSM follow up tests. Inadequate DSM occurred in 1/33 (3%) in the R group and 2/14 (14%) DSM tests in the CI group. The median follow‐up period was 54 and 36 months for the R and CI group, respectively.ConclusionsOur data suggest that epicardial ICDs are reliable and routine follow‐up DSM testing may not be necessary for all patients. DSM testing should be performed in individuals with epicardial ICD systems when there is clinical concern about lead or coil performance.
Efficacy and safety of pulsed field ablation for atrial fibrillation: A systematic review and meta‐analysis
Agarwal, Siddharth , Krishan, Satyam , Deshmukh, Abhishek , Stavrakis, Stavros , Piccini, Jonathan P. , Agarwal, Siddharth , Piccini, Jonathan P , Qamar, Usama , DeSimone, Christopher V. , Asad, Zain Ul Abideen

Pacing and Clinical Electrophysiology | February 11, 2024 | Volume: 47 | Issue: 3 | Pages: 474-480

10.1111/pace.14947 | PMID 38341625 Get It

Hemodynamic response to inhaled nitric oxide in patients with pulmonary hypertension and chronic kidney disease: A retrospective cohort study
Valle, Kathryn T. del , Krowka, Michael J. , Nath, Karl A. , Reddy, Yogesh N.V. , Frantz, Robert P. , DuBrock, Hilary M. , Del Valle, Kathryn T , Reddy, Yogesh N, Frantz, Robert P , DuBrock, Hilary M , Nishimura, Rick , Schinstock, Carrie A. , Burger, Charles D. , Prakash, Y. S.

Pulmonary Circulation | February 10, 2024 | Volume: 14 | Issue: 1 | Pages: No page available

10.1002/pul2.12341 | PMID 38344073 Get It

AbstractPulmonary hypertension (PH) associated with chronic kidney disease (CKD) (PH‐CKD) affects approximately 20%–40% of CKD patients and is associated with increased morbidity and mortality. PH and CKD are both pathophysiologically associated with nitric oxide (NO) deficiency. The NO pathway, an important therapeutic domain in pulmonary arterial hypertension (PAH), is an intriguing but unexplored target in PH‐CKD. We sought to improve understanding of the clinical significance of the NO pathway in patients with PH‐CKD by assessing the hemodynamic response to inhaled NO (iNO) during right heart catheterization (RHC). In this retrospective cohort study, patients with diagnosis codes of PH and stage IV/V CKD or end‐stage renal disease and estimated glomerular filtration rate < 60 mL/min/body surface area who underwent RHC and hemodynamic drug study between July 2011 and June 2021 were eligible. Patients with mean pulmonary artery pressure (mPAP) > 20 mmHg and pulmonary vascular resistance (PVR) > 3 Wood units were included. The final cohort included 37 patients (45.9% female, mean age 72.5 ± 9.7 years). A total of 56.7% of the cohort (21/37) had precapillary PH, while 43.2% (16/37) had combined precapillary postcapillary PH (Cpc‐PH). Median survival was 3.1 years after RHC. iNO was associated with a significant decrease in both mPAP and PVR. Hemodynamic changes in mPAP and PVR were similar in precapillary and Cpc‐PH groups. Among a small subset (n = 14) who were subsequently treated with PAH‐targeted therapy, treatment response was mixed and did not reveal significant benefit. Further studies are warranted to better define the potential role of PAH therapy in PH‐CKD.
Using PAH‐SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung disease
Bailey, M. , Durst, Louise A., Cajigas, Héctor , Kane, Garvan C. , Krowka, Michael J. , Kushwaha, Sudhir S. , McCully, Robert B. , Murphy, Joseph G. , Reddy, Yogesh N.V. , Frantz, Robert P. , Bailey, Morgan , Durst, Louise, Cajigas, Hector R , Reddy, Yogesh N, DuBrock, Hilary M , Nishimura, Rick , Frantz, Robert P , DuBrock, Hilary M.

Pulmonary Circulation | February 10, 2024 | Volume: 14 | Issue: 1 | Pages: No page available

10.1002/pul2.12343 | PMID 38344072 Get It

AbstractChronic lung disease (CLD) is the second leading cause of pulmonary hypertension (PH) and is associated with significant morbidity and mortality. Although PH associated with CLD (PH‐CLD) leads to impaired health‐related quality of life (HRQOL), there are no validated tools to assess HRQOL in PH‐CLD. The Pulmonary Arterial Hypertension–Symptoms and Impact Questionnaire (PAH‐SYMPACT) is an HRQOL instrument aimed at assessing the symptoms and impact of PH on overall function and well‐being. We performed a single‐center prospective cohort study using PAH‐SYMPACT scores to compare symptoms, exercise capacity and HRQOL in patients with PAH and PH‐CLD. One hundred and twenty‐five patients (99 patients with idiopathic/heritable PAH and 26 with PH‐CLD) completed the PAH‐SYMPACT questionnaire which consists of 22 questions that assess HRQOL across four domains: cardiopulmonary (CP) symptoms, cardiovascular (CV) symptoms, physical impact (PI), and cognitive/emotional (CE) impact. Higher scores indicate worse HRQOL. We compared patients with PAH and PH‐CLD using a Wilcoxon rank sum or chi‐squared test as appropriate. Multivariate linear regression analysis was used to assess the relationship between PH classification and SYMPACT scores. Compared to PAH, patients with PH‐CLD were older, more likely to use oxygen and had worse functional class and exercise capacity. While there was no significant difference between the two groups in CP, CV, or CE domain scores, patients with PH‐CLD had significantly worse PI scores by univariate (1.79 vs. 1.13, p < 0.001) and multivariate analysis (1.61 vs. 1.17, p = 0.02) and overall worse SYMPACT scores (1.19 vs. 0.91, p = 0.03). In conclusion, patients with PH‐CLD have worse HRQOL as assessed by the PAH‐SYMPACT questionnaire versus patients with PAH. Although PAH‐SYMPACT has not been validated in PH‐CLD, the results of this study can guide clinicians in understanding the symptoms and impact of PH‐CLD relative to PAH.
Arthroscopic Medial Meniscus Posterior Horn Direct Anchor Root Repair: Transtibial Approach With Knotless Adjustable Aperture Fixation
Lee, Dustin R., Clark, Sean C. , Daniel, Adam V. , Krych, Aaron J. , Smith, Patrick A. , Krych, Aaron J

Arthroscopy Techniques | February 10, 2024 | Volume: 13 | Issue: 5 | Pages: No page available

10.1016/j.eats.2024.102934 | PMID 38835457 Get It

Abstract The integrity of the posterior meniscus root attachment is vital for the preservation of knee joint biomechanics. Meniscus root tears treated nonoperatively or with meniscectomy lead to poor functional outcomes and progressive knee degeneration. Repair returns knee biomechanics back to the intact state and has an established record of positive mid‐term to long‐term results. Although transtibial pullout repair has been the gold standard, innovation is needed to overcome the limitations inherent to traditional approaches. The latest generation of transtibial pullout repair devices is adjustable, permits suture anchor placement directly into the root footprint, and has demonstrated encouraging early results in biomechanical analysis. This Technical Note describes an arthroscopic technique for medial meniscus posterior root repair that uses a knotless adjustable implant (SutureLoc; Arthrex) for aperture fixation via a transtibial approach with intratunnel soft anchor direct fixation and rip‐stop suture configuration. Technique Video video See video under supplementary data.